ADARx Pharmaceuticals
ADRX----
全部股东
股东类型
- 风投/私募41.58%
- 公众及其他41.36%
- 个人与内部人士7.47%
- 机构投资者5.01%
- 私营企业4.58%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
OrbiMed Advisors LLC | 22.13% | 2,479.40 万 | -- | +2,479.40 万 | |
Eli Lilly Investment Consulting (Shanghai) Co., Ltd. | 10.58% | 1,185.87 万 | -- | +1,185.87 万 | |
SR One Capital Management, LP | 8.87% | 993.67 万 | -- | +993.67 万 | |
Li Zhen | 5.23% | 586.12 万 | -- | +586.12 万 | |
Bcls Fund III Investments, Lp | 4.58% | 512.90 万 | -- | +512.90 万 | |
TCG Crossover Management, LLC | 3.20% | 359.03 万 | -- | +359.03 万 | |
Rui ZhuChief Technology Officer | 2.24% | 251.19 万 | -- | +251.19 万 | |
T. Rowe Price Group, Inc. | 1.75% | 196.20 万 | -- | +196.20 万 | |
Vanguard Capital Management, LLC | 0.04% | 5.01 万 | -- | +5.01 万 | |
Columbia Management Investment Advisers, LLC | <0.01% | 8,520.00 | -- | +8,520.00 | |
Vanguard Portfolio Management, LLC | <0.01% | 4,548.00 | -- | +4,548.00 | |
A. MacLeodChief Scientific Officer | 0.00% | 0.00 | -- | +0 |